CN Patent

CN120591230B — 一种甲基转移酶CicOMT10突变体、制备方法、生物材料和应用

Assigned to Guangzhou Cadre Health Management Center Guangzhou 11th People's Hospital Guangzhou Public Officials Mental Health Service Center · Expires 2025-11-25 · 0y expired

What this patent protects

本发明涉及一种甲基转移酶CicOMT10突变体、制备方法、生物材料和应用。所述甲基转移酶突变体是以氨基酸序列如SEQ ID NO:1所示CicOMT10酶经突变而成，所述突变包括：第179位的天冬酰胺突变为丙氨酸；和/或，第316位的苏氨酸突变为丙氨酸。本发明的甲基转移酶突变体，能够高效将圣草酚转化为橙皮素。

USPTO Abstract

本发明涉及一种甲基转移酶CicOMT10突变体、制备方法、生物材料和应用。所述甲基转移酶突变体是以氨基酸序列如SEQ ID NO:1所示CicOMT10酶经突变而成，所述突变包括：第179位的天冬酰胺突变为丙氨酸；和/或，第316位的苏氨酸突变为丙氨酸。本发明的甲基转移酶突变体，能够高效将圣草酚转化为橙皮素。

Drugs covered by this patent

Patent Metadata

Patent number: CN120591230B
Jurisdiction: CN
Classification: —
Expires: 2025-11-25
Drug substance claim: No
Drug product claim: No
Assignee: Guangzhou Cadre Health Management Center Guangzhou 11th People's Hospital Guangzhou Public Officials Mental Health Service Center
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.